Background: Chronic conditions such as diabetes mellitus and cardiovascular disease are common in people with gout and are associated with poorer quality of life and higher mortality. However, our understanding of the role of psychological comorbidity in gout remains unclear. Frequent experience of severe pain, social isolation and strained family relationships may impact negatively on psychological health and influence health-seeking behaviour. This matched retrospective cohort study aimed to examine the association between gout and subsequent consultation for anxiety & depression in a UK primary care population. Methods: The study was undertaken using data from a general practice consultation database (CiPCA), gathered from nine general practices in North Staffordshire. Patients aged 18 years who consulted with gout between 2000 and 2008 were identified by Read code and each matched to 4 controls by age, gender, year of consultation and general practice. A consultation for either anxiety or depression, subsequent to the gout diagnosis, was defined from a relevant Read code gained between 2000 and 2011. Several other gout-related comorbidities (e.g. hypertension) were also recorded by Read code. Cox regression model was used to examine the association between gout and subsequent anxiety & depression consultation (new episodes), adjusting for age, gender, deprivation, year of consultation, general practice and comorbidities. Hazard ratio (HR) and 95% CI were reported for gout cases vs matched controls. Results: 1689 patients with gout were compared with 6,756 control patients. Mean age was 63 years (Standard deviation 16) and 24% were female. Of gout patients, 15.3% & 9.7% had consulted for anxiety & depression respectively, this was in comparison with 14.2% & 9.5% of the controls. Adjusted cox regression analysis found no association between gout and time to consultation for anxiety (HR 1.04, 95% CI 0.9, 1.2) or depression [0.88 (0.7, 1.1)] compared with controls. Across gout patients and matched controls, being younger and female was associated with a propensity to consult for anxiety & depression. With each year from first diagnosis (gout and controls), there was a trend of increasing consultation for anxiety. The presence of hypertension and alcoholism comorbidity was associated with an increased probability of consultation for anxiety & depression. Conclusion: Despite the psychological burden which gout may be expected to impart on patients, time to consultation for anxiety & depression in UK primary care was equivalent to matched controls. This may relate to the prolonged asymptomatic inter-critical period between gout attacks during which psychological burden may ease. However, as under-reporting of both anxiety & depression in primary care is common and the severity & disease characteristics of gout, anxiety & depression could not be established from medical records, further research considering these factors would be of benefit. The aim of the COP was to identify barriers and enablers for local implementation of research findings. Methods: Key stakeholders (n ¼ 85) from the North West Midlands and representing general practice, physiotherapy, commissioners, patient groups, rheumatology and pain management were identified. They were invited to participate in a COP event with an open discussion to identify the key barriers and enablers for integrating the STaRT Back findings into daily practice. Firstly, the clinical applicability of the trial results was presented. Secondly, stakeholders were divided into two groups, one of medical practitioners (Group 1), the other of the remaining stakeholders (Group 2). Facilitated discussions: explored barriers, enablers and priorities for implementation. Finally each group was asked to identify three important implementation messages. Results: Of 85 stakeholders, 31 (36%) attended the open discussion: general practitioners (n ¼ 10), patients (n ¼ 5), clinical managers (n ¼ 3), physiotherapists (n ¼ 3), commissioners (n ¼ 2), rheumatologists (n ¼ 2), research managers (n ¼ 2), researchers (n ¼ 2), anaesthetist (n ¼ 1), physiotherapy educator (n ¼ 1). Group 1 identified barriers such as lack of belief in screening tools, GP fatigue with guidance and concerns over restricting the clinical freedom culture among GPs. Enablers included receiving feedback on the clinical outcomes from using the tool, quality indicators for back pain and embedding the tool electronically in computer systems (Table 1) . Group 2 identified barriers such as organizational structures, lack of training funds and lack of understanding of the commissioning processes. Enablers included use of social media, cascading information through a buddy system or research facilitators, better communication between research and clinicians (and utilizing educational events) and provision of tools that make it easier for clinicians to adopt new systems (Table 1) . Conclusion: A COP identified barriers and enablers for local implementation of research findings into clinical practice. The COP process allowed participants to find solutions based on their local knowledge. Greater engagement and alliances across all stakeholders has identified key priorities for translating STaRT Back across a large local health economy.
Disclosure statement: The authors have declared no conflicts of interest. Results: Severe pain (often in the toe) was a frequent reason for consultation. Diagnosis was not always straightforward, for example, people were sometimes thought to have broken a bone or have an infection. The primary concern for most patients at diagnosis was how best to reduce their pain. Many patients felt that their GP understood how painful the condition was although some felt GPs did not acknowledge the significance of their pain. There was a desire for more information provision at diagnosis. Patient experience of treatment varied widely, from those who were happy to take prophylactic treatment to prevent acute attacks, through to those who wished to manage the condition through diet and lifestyle, only taking medication for acute attacks. Making the decision to start long-term preventative treatment could take a few years, either because treatment was not offered earlier or because patients initially tried to manage the condition with lifestyle change before trying medication. We investigated adherence to the guidelines in primary care with a retrospective crosssectional study of patient records. Methods: We identified patients with a Read code for PMR in five primary care practices. We collected data from the electronic records of 6 cases from one practice as a pilot and the first 10 patients from four practices with a new diagnosis of PMR after 01/01/2006. We reviewed records for 6 months before and 2 years after the date of diagnosis. We compared documentation of the diagnostic process with five core inclusion criteria (age >50 years, symptom duration more than 2 weeks, shoulder or pelvic girdle aching, morning stiffness >45 minutes, acute phase response) and 11 recommended investigations. We ascertained the starting dose of prednisolone, assessment of response to treatment, reduction regimen for prednisolone, coprescription of bone protection and referrals. Results: Out of 46 patients, 3 died during follow-up and 4 were subsequently diagnosed with another disorder. Five core inclusion criteria were documented in 3 (7%) and four inclusion criteria in 29 (63%) cases. Only 3 (7%) cases had record of morning stiffness >45 minutes. Whilst 44 (96%) patients had inflammatory markers tested, 37 (84%) had a full blood count and fewer than 10% had a chest X-ray or urinalysis performed. No patient had all eleven investigations performed. Starting doses of prednisolone ranged from 5-30 mg daily with 27 (59%) patients commencing on 15 mg. A clinical response to prednisolone was documented within 1 week in 27 (59%) and normalization of raised inflammatory markers in 22/38 cases. Only 24 patients had a documented reduction in prednisolone within 4 weeks and 14/40 (35%) had stopped steroids at 2 years. Bone protection was prescribed in 27 (62%) patients within 1 month of starting prednisolone. The application of BSR & BHPR referral guidelines would have resulted in referral of 31 (67%) of cases; 16 (35%) were actually referred. Conclusion: The BSR & BHPR guidelines were not closely adhered to in patients diagnosed with PMR in primary care. The most poorly recorded inclusion criterion was morning stiffness >45 minutes and patients rarely underwent full investigation for exclusion of other conditions. Reduction and cessation of steroids was slower than recommended. However, adherence to the guidelines would have resulted in referral of two thirds of the patients for specialist opinion.
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Disclosure statement: The authors have declared no conflicts of interest. Background: A good quality referral letter is vital to any referral management system. Recent guidelines for referral of suspected inflammatory arthritis make it more imperative for referral letters to
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